Shopping Cart 0
Cart Subtotal
AED 0

BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

BioMarin Pharmaceutical Inc.-Strategy, SWOT and Corporate Finance Report

Summary

BioMarin Pharmaceutical Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or 'the company'), a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.

Scope

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis

- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments

- Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

BioMarin Pharmaceutical Inc.: Company Overview 9

BioMarin Pharmaceutical Inc.: Overview and Key Facts 9

BioMarin Pharmaceutical Inc.: Overview 9

BioMarin Pharmaceutical Inc.: Key Facts 9

BioMarin Pharmaceutical Inc.: Key Employees 11

BioMarin Pharmaceutical Inc.: Key Employee Biographies 12

BioMarin Pharmaceutical Inc.: Major Products and Services 19

BioMarin Pharmaceutical Inc.: Company History 20

BioMarin Pharmaceutical Inc.: Management Statement 24

BioMarin Pharmaceutical Inc.: Locations and Subsidiaries 26

BioMarin Pharmaceutical Inc.: Key Competitors 27

BioMarin Pharmaceutical Inc.: Company Analysis 28

BioMarin Pharmaceutical Inc.: Business Description 28

BioMarin Pharmaceutical Inc.: SWOT Analysis 30

BioMarin Pharmaceutical Inc.: SWOT Overview 30

BioMarin Pharmaceutical Inc.: Strengths 30

BioMarin Pharmaceutical Inc.: Weaknesses 31

BioMarin Pharmaceutical Inc.: Opportunities 31

BioMarin Pharmaceutical Inc.: Threats 33

BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity 35

BioMarin Pharmaceutical Inc.: Financial Deals Overview 35

BioMarin Pharmaceutical Inc.: Targets and Partners 37

BioMarin Pharmaceutical Inc.: Top Deals 2014-2018YTD 38

BioMarin Pharmaceutical Inc.: Advisors 39

BioMarin Pharmaceutical Inc.: Top Legal Advisors 39

BioMarin Pharmaceutical Inc.: Top Financial Advisors 39

BioMarin Pharmaceutical Inc.: Mergers and Acquisitions 40

BioMarin Pharmaceutical Inc.: Capital Raising 41

BioMarin Pharmaceutical Inc.: Partnership 42

BioMarin Pharmaceutical Inc.: Recent Developments 43

BioMarin Pharmaceutical

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

BioMarin Pharmaceutical Inc.-Strategy, SWOT and Corporate Finance Report

Summary

BioMarin Pharmaceutical Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or 'the company'), a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.

Scope

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis

- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments

- Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

BioMarin Pharmaceutical Inc.: Company Overview 9

BioMarin Pharmaceutical Inc.: Overview and Key Facts 9

BioMarin Pharmaceutical Inc.: Overview 9

BioMarin Pharmaceutical Inc.: Key Facts 9

BioMarin Pharmaceutical Inc.: Key Employees 11

BioMarin Pharmaceutical Inc.: Key Employee Biographies 12

BioMarin Pharmaceutical Inc.: Major Products and Services 19

BioMarin Pharmaceutical Inc.: Company History 20

BioMarin Pharmaceutical Inc.: Management Statement 24

BioMarin Pharmaceutical Inc.: Locations and Subsidiaries 26

BioMarin Pharmaceutical Inc.: Key Competitors 27

BioMarin Pharmaceutical Inc.: Company Analysis 28

BioMarin Pharmaceutical Inc.: Business Description 28

BioMarin Pharmaceutical Inc.: SWOT Analysis 30

BioMarin Pharmaceutical Inc.: SWOT Overview 30

BioMarin Pharmaceutical Inc.: Strengths 30

BioMarin Pharmaceutical Inc.: Weaknesses 31

BioMarin Pharmaceutical Inc.: Opportunities 31

BioMarin Pharmaceutical Inc.: Threats 33

BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity 35

BioMarin Pharmaceutical Inc.: Financial Deals Overview 35

BioMarin Pharmaceutical Inc.: Targets and Partners 37

BioMarin Pharmaceutical Inc.: Top Deals 2014-2018YTD 38

BioMarin Pharmaceutical Inc.: Advisors 39

BioMarin Pharmaceutical Inc.: Top Legal Advisors 39

BioMarin Pharmaceutical Inc.: Top Financial Advisors 39

BioMarin Pharmaceutical Inc.: Mergers and Acquisitions 40

BioMarin Pharmaceutical Inc.: Capital Raising 41

BioMarin Pharmaceutical Inc.: Partnership 42

BioMarin Pharmaceutical Inc.: Recent Developments 43

BioMarin Pharmaceutical

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS